CAH

Rating buyAI Memo

Cardinal Health

As of 2026-02-08/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-02-08 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Analyst target revisions and guidance commentary • 2026-05-01

Expected move: +24%

Biggest risk

Contract pressure, reimbursement headwinds, or execution failures on cost programs compress margins and keep valuation nearer recent lows around $208.

Invalidation

Break below $208 or thesis failure.

What would change my mind?

Sustained margin improvement and continued steady demand for pharmaceutical distribution lift multiples toward the high analyst range, validating a move toward the $270 area.

Research note

Recommendation

buy

Confidence

medium

As of

2026-02-08

Base target

$243

p=60%

Bull target

$270

p=20%

Bear target

$208

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Next quarterly earnings release
Execution of margin expansion / cost-savings initiatives
Sustained margin improvement and continued steady demand for pharmaceutical distribution lift multiples toward the high analyst range, validating a move toward the $270 area.

BearKey bullets

Distribution contract renewal and pricing pressure
Execution risk on cost-savings and margin initiatives
Regulatory or compliance actions affecting distribution

WatchKey bullets

Analyst target revisions and guidance commentary

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $243 (p=60%)

Bull/Bear spread: +37% / +6%

Vs latest close: Bull +37% · Base +24% · Bear +6%

Scenario probabilities

Bull Target: $270 (p=20%)Base Target: $243 (p=60%)Bear Target: $208 (p=20%)

Commentary

Market tone is cautiously constructive after recent beats and a guidance raise, with analysts skewing modestly higher than the current price [#SERP-7][#SERP-1]. Short-term sentiment tracks upcoming results and any guidance changes, while longer-term views hinge on margin execution and contract stability [#SERP-5].

As of 2026-02-08 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Sustained margin improvement and continued steady demand for pharmaceutical distribution lift multiples toward the high analyst range, validating a move toward the $270 area.

Bear Case

Contract pressure, reimbursement headwinds, or execution failures on cost programs compress margins and keep valuation nearer recent lows around $208.

Drivers

Scannable catalysts and supporting factors

Next quarterly earnings release
Execution of margin expansion / cost-savings initiatives

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-02-08Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$239.80

Range (USD)

$66.00 - $270.00

Count

Query: Cardinal Health Inc Common (CAH) analyst consensus price target high low average

Cardinal Health (CAH) Stock Forecast and Price Target 2026
Search result #1
According to the 16 analysts' twelve-month price targets for Cardinal Health, the average price target is $241.27. The highest price target for CAH is $270.00, ...
Extracted: $241.27, $270.00Open source
Cardinal Health (CAH) Stock Forecast & Price Target
Search result #2
According to projections from 15 analysts, the average 12-month price target for Cardinal Health is 243.07, with a high estimate of 270 and a low estimate of ...
Open source
Cardinal Health, Inc.: Target Price Consensus and Analysts ...
Search result #3
Mean consensus. BUY ; Number of Analysts. 16 ; Last Close Price. 226.32USD ; Average target price. 243.07USD ; Spread / Average Target. +7.40%.
Extracted: $226.32, $243.07Open source
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & ...
Search result #4
News headlines Cardinal Health (CAH) shares rose 5.3% after strong Q2 results and an increase in full-year earnings guidance. The company reported $66 ...
Extracted: $66.00Open source
CAH Stock Price Quote & News - Cardinal Health
Search result #5
Morgan Stanley raised the firm's price target on Cardinal Health (CAH) to $255 from $245 and keeps an Overweight rating on the shares. The risk reward for Cardi ...
Extracted: $255.00, $245.00Open source
Cardinal Health Analyst Ratings and Price Targets
Search result #6
Cardinal Health Inc has a consensus price target of $178.16 based on the ratings of 19 analysts. The high is $245 issued by Morgan Stanley on January 29, ...
Extracted: $178.16, $245.00Open source

Scenarios

Bull Target (Scenario probability)

$270 / p=20% prob

Base Target (Scenario probability)

$243 / p=60% prob

Bear Target (Scenario probability)

$208 / p=20% prob

Price $197 as of 2026-05-29

Nearest Scenario: Bear (∆ 6%)

Targets vs latest close: Bull +37% · Base +24% · Bear +6%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-05-01
Analyst target revisions and guidance commentary
Periodic analyst refreshes and management commentary can reprice consensus (assume end of typical 12-month target update window) [#SERP-1][#SERP-5]; date chosen as window end per assumption.
Prob 55.00% • Move 6.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

Next quarterly earnings release
2026-05-09
Upcoming quarterly results and any guidance updates; market has recently reacted to Q2 beats and guidance changes [#SERP-7][#SERP-4].
Prob 70% • Move 5% • Priced-in 60%

Long-term Catalysts

Months to a year

Execution of margin expansion / cost-savings initiatives
2027-02-08
Company initiatives to improve distribution margins and SG&A leverage—material impact expected longer term if sustained [#SERP-7].
Prob 50% • Move 18% • Priced-in 30%

Risks

Distribution contract renewal and pricing pressure
Execution risk on cost-savings and margin initiatives
Regulatory or compliance actions affecting distribution

Peers

Symbol	Summary
MCK	Largest pharma distributor; serves as scale/market-share benchmark.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Cardinal Health Inc Common (CAH) analyst consensus price target high low average
Analysis date: 2026-02-08

AI Stock Memo: CAH - Cardinal Health - RankAlpha